Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double-Blind, Placebo-Controlled Study.

Clin Pharmacol Drug Dev · 2026 · PMC12814314 · PMID 40884302

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Mean percentage change from baseline at 2 h showed an increasing trend in prolactin concentrations between dose levels of 3–12 mg, but a plateau was observed thereafter.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.